Nobody announced it.
Clinical AI got promoted anyway.
It moved from assistant.
To decision-shaper.
One deployment at a time.
One workflow at a time.
Until the recommendation
was shaping the call.
A promotion is supposed to come
with accountability.
That part never arrived.
The capability got the new title.
The ownership seat stayed empty.
Five things change
when clinical AI gets promoted.
↳ Its outstanding became the baseline.
↳ The clinician loses time for what made the call safe.
↳ The accountability lines move overnight.
↳ The responsibility arrives before the governance.
↳ The decisions reach bigger rooms, faster.
One thing has to catch up.
The Accountability Gap™ (TAG™)
does not close with a title change.
It closes when a name
is attached to the new authority.
You already know which deployment
got promoted in your institution
without anyone owning the new title.
The only question is whether
the accountability arrives
before the harm does.
Mo Johnson, MD MBA is a cardiothoracic surgeon and the founder of GPe Research. He created The Accountability Gap™ (TAG™), which names the moment the AI stops and the named owner starts. MedicoVigilance™ covers clinical AI. FinVigilance™ covers financial AI. Field Notes are short dispatches from the accountability frontier, published at tagframework.com.
Follow the work on LinkedIn: linkedin.com/in/mo-johnson

